SE7608771L - Forfarande for framstellning av extrakt ur det hematopoetiska systemet - Google Patents
Forfarande for framstellning av extrakt ur det hematopoetiska systemetInfo
- Publication number
- SE7608771L SE7608771L SE7608771A SE7608771A SE7608771L SE 7608771 L SE7608771 L SE 7608771L SE 7608771 A SE7608771 A SE 7608771A SE 7608771 A SE7608771 A SE 7608771A SE 7608771 L SE7608771 L SE 7608771L
- Authority
- SE
- Sweden
- Prior art keywords
- chalones
- leucocytes
- extracts
- hemopoietic
- granulocytic
- Prior art date
Links
- 239000000284 extract Substances 0.000 title abstract 4
- 108010011008 Chalones Proteins 0.000 abstract 3
- 230000002607 hemopoietic effect Effects 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 230000000527 lymphocytic effect Effects 0.000 abstract 1
- 208000025113 myeloid leukemia Diseases 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB32659/75A GB1579120A (en) | 1975-08-05 | 1975-08-05 | Extracts of the haemopoietic system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7608771L true SE7608771L (sv) | 1977-02-06 |
Family
ID=10342062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7608771A SE7608771L (sv) | 1975-08-05 | 1976-08-04 | Forfarande for framstellning av extrakt ur det hematopoetiska systemet |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4294824A (fr) |
| JP (1) | JPS5218807A (fr) |
| AR (1) | AR211931A1 (fr) |
| AU (1) | AU515950B2 (fr) |
| BE (1) | BE844875A (fr) |
| CA (1) | CA1063019A (fr) |
| DE (1) | DE2635065C2 (fr) |
| DK (1) | DK350876A (fr) |
| FI (1) | FI762178A (fr) |
| FR (1) | FR2320106A1 (fr) |
| GB (1) | GB1579120A (fr) |
| IE (1) | IE44378B1 (fr) |
| IN (1) | IN144537B (fr) |
| IT (1) | IT1062655B (fr) |
| LU (1) | LU75535A1 (fr) |
| NL (1) | NL7608651A (fr) |
| NZ (1) | NZ181653A (fr) |
| SE (1) | SE7608771L (fr) |
| ZA (1) | ZA764643B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU182087B (en) * | 1980-01-15 | 1983-12-28 | Mta Kiserleti Orvostudomanyi K | Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia |
| JPS6339609Y2 (fr) * | 1980-11-21 | 1988-10-18 | ||
| JPS59141520A (ja) * | 1983-02-02 | 1984-08-14 | Kyowa Hakko Kogyo Co Ltd | Ｄｎａ合成抑制物質 |
| CA2129436A1 (fr) * | 1992-12-04 | 1994-06-05 | Satoko Yamada | Compositions contenant un facteur d'inhibition hematopoietique |
| US5882328A (en) * | 1995-01-13 | 1999-03-16 | Qlt Phototherapeutics, Inc. | Method to prevent transplant rejection |
| AU706857B2 (en) * | 1995-12-21 | 1999-06-24 | Genzyme Corporation | Method for lysing cells |
| FR2773818B1 (fr) * | 1998-01-21 | 2000-02-18 | Pasteur Merieux Serums Vacc | Procede et dispositif de lyse de bacteries |
| DE69920209T2 (de) | 1998-03-26 | 2005-10-06 | Viranative Ab | Verfahren zur kontinuierlichen reinigung und konzentrierung von leukozyten aus dem blut |
| US6364907B1 (en) | 1998-10-09 | 2002-04-02 | Qlt Inc. | Method to prevent xenograft transplant rejection |
| US6664049B1 (en) * | 1999-01-20 | 2003-12-16 | Aventis Pasteur S.A. | Method and device for cell lysis |
| US20040208855A1 (en) * | 1999-11-17 | 2004-10-21 | Allison Beth Anne | Use of PDT to inhibit intimal hyperplasia |
| DE102004047262A1 (de) * | 2004-09-24 | 2006-04-06 | Ipss International Pharmaceutical Strategies & Solutions | Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen |
| EP1640012A1 (fr) * | 2004-09-24 | 2006-03-29 | Salama, Zoser B. nat.rer.Dr. | Agents pharmaceutiques comprenant des constituants du sang 10 kDa et l'utilisation dans la prophylaxe et dans le traitement des troubles du système immunitaire |
| US20060067942A1 (en) * | 2004-09-24 | 2006-03-30 | Salama Zoser B | Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals |
-
1975
- 1975-08-05 GB GB32659/75A patent/GB1579120A/en not_active Expired
-
1976
- 1976-07-05 AR AR264235A patent/AR211931A1/es active
- 1976-07-30 FI FI762178A patent/FI762178A/fi not_active Application Discontinuation
- 1976-07-30 IE IE1697/76A patent/IE44378B1/en unknown
- 1976-08-02 NZ NZ181653A patent/NZ181653A/xx unknown
- 1976-08-02 ZA ZA00764643A patent/ZA764643B/xx unknown
- 1976-08-04 DE DE2635065A patent/DE2635065C2/de not_active Expired
- 1976-08-04 DK DK350876A patent/DK350876A/da not_active Application Discontinuation
- 1976-08-04 CA CA258,437A patent/CA1063019A/fr not_active Expired
- 1976-08-04 LU LU75535A patent/LU75535A1/xx unknown
- 1976-08-04 FR FR7623829A patent/FR2320106A1/fr active Granted
- 1976-08-04 NL NL7608651A patent/NL7608651A/xx not_active Application Discontinuation
- 1976-08-04 IT IT50750/76A patent/IT1062655B/it active
- 1976-08-04 SE SE7608771A patent/SE7608771L/xx not_active Application Discontinuation
- 1976-08-04 BE BE169552A patent/BE844875A/fr not_active IP Right Cessation
- 1976-08-05 JP JP51093520A patent/JPS5218807A/ja active Pending
- 1976-08-05 IN IN1401/CAL/76A patent/IN144537B/en unknown
- 1976-08-05 AU AU16614/76A patent/AU515950B2/en not_active Expired
-
1978
- 1978-06-19 US US05/917,076 patent/US4294824A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2320106B1 (fr) | 1980-11-07 |
| IN144537B (fr) | 1978-05-13 |
| NZ181653A (en) | 1979-01-11 |
| GB1579120A (en) | 1980-11-12 |
| DK350876A (da) | 1977-02-06 |
| AU1661476A (en) | 1978-02-09 |
| FR2320106A1 (fr) | 1977-03-04 |
| IT1062655B (it) | 1984-10-20 |
| US4294824A (en) | 1981-10-13 |
| LU75535A1 (fr) | 1978-02-13 |
| DE2635065A1 (de) | 1977-02-17 |
| JPS5218807A (en) | 1977-02-12 |
| AU515950B2 (en) | 1981-05-14 |
| IE44378B1 (en) | 1981-11-04 |
| FI762178A (fr) | 1977-02-06 |
| AR211931A1 (es) | 1978-04-14 |
| NL7608651A (nl) | 1977-02-08 |
| BE844875A (fr) | 1977-02-04 |
| CA1063019A (fr) | 1979-09-25 |
| IE44378L (en) | 1977-02-05 |
| DE2635065C2 (de) | 1983-10-27 |
| ZA764643B (en) | 1978-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7608771L (sv) | Forfarande for framstellning av extrakt ur det hematopoetiska systemet | |
| DK368283A (da) | Fremgangsmaade til udvinding af rene krystallinske anhydropentitoler, mono- og/eller dianhydrohexitoler | |
| MX169362B (es) | Procedimiento de obtencion de un extracto antioxidante de especias | |
| PT86509A (fr) | Procede de preparation de complexes phospholipidiques d:extraits de vitis vinifera | |
| NO170316C (no) | Fremgangsmaate ved fremstilling av en lipaseekstrakt elleren lipase | |
| EP0133151A3 (fr) | Onguent pour la peau | |
| Kuo et al. | Subcellular distribution of ascorbic acid in rat brain | |
| SE8100614L (sv) | Humant relaxin och sett for framstellning derav | |
| NL169337C (nl) | Werkwijze voor de bereiding van vormmassa's van macromoleculaire thermoplastische polycarbonaten, alsmede daarvan vervaardigd gevormd voortbrengsel. | |
| MX161477A (es) | Procedimiento para extraer los constituyentes de la manzanilla | |
| DK155499C (da) | Fremgangsmaade til fremstilling af blodplasma-fraktioner | |
| JPS56120621A (en) | Preparation of substance having wound remedying action | |
| ES493491A0 (es) | Procedimiento para la separacion de leucina, isoleucina y valina | |
| DK49783D0 (da) | Fremgangsmade til fremstilling af panthenolderivater | |
| Cozad | Speechreading skill and communication difficulty of children and young adults with unilateral hearing loss. | |
| BE824243A (fr) | Procede de separation de la leucine et de l'isoleucine | |
| JPS5634352A (en) | Separating membrane for blood separation and its manufacture | |
| JPS57155991A (en) | Preparation of superoxide dismutase derived from human placenta | |
| GB904803A (en) | Process for the manufacture of a waterproof cape | |
| GB1426008A (en) | Separation and collection of egg components | |
| JPS5718620A (en) | Production of antitumor substance | |
| RO82582B1 (ro) | Ovule cu actiune antiseptica si antiinflamatoare | |
| Erwin | To what degree was Freud wrong—and how much difference does it make in psychotherapy? | |
| KR920000256A (ko) | 인삼엑기스의 추출방법 | |
| Gatehouse et al. | The roles of the pinna and the external auditory meatus in monaural sound localization. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7608771-7 |